The current CVM market cap is 24.07M. The company's latest EPS is USD -0.5263 and P/E is -0.78.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.18M | -7.47M | -6.49M | -7.08M | -6.67M |
Net Income | -8.37M | -7.63M | -6.71M | -7.24M | -7.52M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 536k | 559k | 0 | 0 | 0 |
Operating Income | -20.12M | -28.98M | -36.19M | -36.06M | -31.48M |
Net Income | -22.14M | -30.28M | -36.71M | -37.63M | -32.37M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 32.32M | 30.53M | 28.71M | 30.05M | 24.07M |
Total Liabilities | 17.53M | 17.31M | 16.06M | 15.74M | 15.6M |
Total Equity | 14.79M | 13.22M | 12.65M | 14.31M | 8.47M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 27.62M | 40.54M | 75.87M | 50.52M | 30.53M |
Total Liabilities | 22.49M | 20.81M | 19.34M | 18.36M | 17.31M |
Total Equity | 5.13M | 19.73M | 56.53M | 32.16M | 13.22M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -17.8M | -22.85M | -4.89M | -9.42M | -14M |
Investing | -362k | -372k | -65k | -65k | -88k |
Financing | 629k | 4.69M | 4.05M | 10.64M | 10.32M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | N/A | -15.28M | -18.79M | -18.24M | -22.85M |
Investing | N/A | -2.7M | -15.19M | 5.49M | -372k |
Financing | N/A | 25.04M | 54.52M | -638k | 4.69M |
Market Cap | 24.07M |
Price to Earnings Ratio | -0.78 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 6.08 |
Price to Book Ratio | 1.91 |
Dividend Yield | - |
Shares Outstanding | 61.49M |
Average Volume (1 week) | 1.67M |
Average Volume (1 Month) | 2.31M |
52 Week Change | -84.65% |
52 Week High | 3.08 |
52 Week Low | 0.3567 |
Spread (Intraday) | 0.04 (8.95%) |
Company Name | Cel Sci Corporation New |
Address |
7700 e arapahoe rd centennial, colorado 80112 1268 |
Website | https://www.cel-sci.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.